FDA.reportPublic FDA data

Hemopropin Extra Strength Hemorrhoidal Ointment

Manufacturer
Apipharmausa, LLC
Effective date
2023-12-01
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
legacy-cache
Hydrated at
2026-08-01 21:19:26

Label at a glance#

ProductHemopropin Extra Strength Hemorrhoidal
Active ingredientLANOLIN, PETROLATUM
Label structure7 sections

Indications and uses

helps relieve itching and discomfort associated with hemorrhoids and inflamed hemorrhoidal tissues temporarily protects irritated areas temporarily relieves burning temporarily protects inflamed, irritated anorectal surface to help make bowel movements less painful

Dosage and administration

Adults: when practical, cleanse the affected area with mild soap and warm water and rinse thoroughly; gently dry by patting or blotting with toilet tissue or a soft cloth before application of this product Apply externally to the affected area up to 6 times daily or after each bowel movement FOR INTRARECTAL USE: attach applicator to tube; lubricate applicator well, then gently insert applicator into the rectum Chi...

Label contents#

Full prescribing information#

Active ingredients

OTC - ACTIVE INGREDIENT SECTION

Lanolin 17.76%

Petrolatum 71.2%

Purpose

OTC - PURPOSE SECTION

Hemorrhoidal Protectant

Uses

INDICATIONS & USAGE SECTION

  • helps relieve itching and discomfort associated with hemorrhoids and inflamed hemorrhoidal tissues
  • temporarily protects irritated areas
  • temporarily relieves burning
  • temporarily protects inflamed, irritated anorectal surface to help make bowel movements less painful

Warnings

WARNINGS SECTION

For rectal use only.

When using this product

OTC - WHEN USING SECTION

do not exceed the recommended daily dosage unless directed by a doctor.

Stop use and consult a doctor if:

OTC - STOP USE SECTION

  • condition worsens or does not improve within 7 days
  • the introduction of the applicator into the rectum causes additional pain or bleeding occurs

If pregnant or breastfeeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

consult a health care professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Adults: when practical, cleanse the affected area with mild soap and warm water and rinse thoroughly; gently dry by patting or blotting with toilet tissue or a soft cloth before application of this product
  • Apply externally to the affected area up to 6 times daily or after each bowel movement
  • FOR INTRARECTAL USE: attach applicator to tube; lubricate applicator well, then gently insert applicator into the rectum
  • Children under 12 years of age: consult a doctor

Other information

SPL UNCLASSIFIED SECTION

  • store in a dry and cool place

Inactive ingredients

INACTIVE INGREDIENT SECTION

Alcohol, propolis wax, roman chamomile, water

Package Labeling: 73061-000-20

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

73061-000-20 - Hemopropin Extra Strength Hemorrhoidal Ointment73061-000-20 - Hemopropin Extra Strength Hemorrhoidal Ointment

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
73061-00073061-000-20

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Name, UNII, Kind table
NameUNIIKind
ALCOHOL3K9958V90MIACT
PROPOLIS WAX6Y8XYV2NOFIACT
WATER059QF0KO0RIACT
LANOLIN7EV65EAW6HACTIB
PETROLATUM4T6H12BN9UACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
357dd3b3-9ef7-8009-e063-6394a90aecbda0801c58-e923-4295-8aef-2ec17481d15c2025-05-19WarningsExact identifier
spl set id: a0801c58-e923-4295-8aef-2ec17481d15c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.